INTERNATIONAL PATENT: HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD., 杭州中美华东制药有限公司 FILES APPLICATION FOR "DOUBLE-STRANDED RNA COMPOSITION CAPABLE OF REGULATING EXPRESSION OF INHBE, CONJUGATE THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF"

GENEVA, Dec. 21 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, GongShu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2025/100647) for "DOUBLE-STRANDED RNA COMPOSITION CAPABLE OF REGULATING EXPRESSION OF INHBE, CONJUGATE THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF" on Jun 12, 2025. With publication no. WO/2025/256587, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted unde...